Chief Computational Scientist
As chief computational scientist at Roivant Sciences, Woody is responsible for the vision, execution and deployment of the computational platform in drug discovery projects. Woody joined Roivant Sciences from Silicon Therapeutics, where he was chief scientific officer. Woody is a recognized leader in computational chemistry and biomolecular simulations and an authority in the emerging field of physics-driven drug design.
Woody previously served as vice president and global head of the applications science at Schrödinger, Inc., a leader in computational chemistry software development. During his tenure at Schrödinger, Woody was also part of the senior management team and was involved in modeling services, methods development and product management. He is a leader in molecular simulations and computer-aided drug design, with more than 90 publications and patents covering novel methods and applications. Woody has published on a broad range of topics including free energy simulations, molecular dynamics, induced-fit docking, virtual screening, lead optimization, selectivity design, cheminformatics and protein design. He is on the editorial board of Chemical Biology & Drug Design and the Journal of Chemical Information and Modeling. Woody currently serves on the program planning committee for The Protein Society‘s 35th Anniversary Symposium. Dr. Sherman also serves on the advisory board at Pharmacelera.
Woody earned a doctor of philosophy degree with Professor Bruce Tidor, Ph.D. at Massachusetts Institute of Technology in Cambridge, Mass.